Skip to navigation Skip to content
  • Woodruff
  • Business
  • Health Sciences
  • Law
  • MARBL
  • Oxford College
  • Theology
  • Schools
    • Undergraduate

      • Emory College
      • Oxford College
      • Business School
      • School of Nursing

      Community

      • Emory College
      • Oxford College
      • Business School
      • School of Nursing
    • Graduate

      • Business School
      • Graduate School
      • School of Law
      • School of Medicine
      • School of Nursing
      • School of Public Health
      • School of Theology
  • Libraries
    • Libraries

      • Robert W. Woodruff
      • Business
      • Chemistry
      • Health Sciences
      • Law
      • MARBL
      • Music & Media
      • Oxford College
      • Theology
    • Library Tools

      • Course Reserves
      • Databases
      • Digital Scholarship (ECDS)
      • discoverE
      • eJournals
      • Electronic Dissertations
      • EmoryFindingAids
      • EUCLID
      • ILLiad
      • OpenEmory
      • Research Guides
  • Resources
    • Resources

      • Administrative Offices
      • Emory Healthcare
      • Academic Calendars
      • Bookstore
      • Campus Maps
      • Shuttles and Parking
      • Athletics: Emory Eagles
      • Arts at Emory
      • Michael C. Carlos Museum
      • Emory News Center
      • Emory Report
    • Resources

      • Emergency Contacts
      • Information Technology (IT)
      • Outlook Web Access
      • Office 365
      • Blackboard
      • OPUS
      • PeopleSoft Financials: Compass
      • Careers
      • Human Resources
      • Emory Alumni Association
  • Browse
    • Works by Author
    • Works by Journal
    • Works by Subject
    • Works by Dept
    • Faculty by Dept
  • For Authors
    • How to Submit
    • Deposit Advice
    • Author Rights
    • Publishing Your Data
    • FAQ
    • Emory Open Access Policy
    • Open Access Fund
  • About OpenEmory
    • About OpenEmory
    • About Us
    • Citing Articles
    • Contact Us
    • Privacy Policy
    • Terms of Use
 
Contact Us

Filter Results:

Year

  • 2015 (1)

Author

  • Bernardini, Laura (1)
  • Binda, Elena (1)
  • Boulis, Nicholas (1)
  • Cantello, Roberto (1)
  • Carletti, Sandro (1)
  • Carriero, Alessandro (1)
  • Cerino, Annalisa (1)
  • Cima, Valentina (1)
  • Cisari, Carlo (1)
  • Domenico, Frondizi (1)
  • Ferrari, Daniela (1)
  • Gaiani, Alessandra (1)
  • Gelati, Maurizio (1)
  • Giorgi, Cesare (1)
  • Glass, Jonathan (1)
  • Maglione, Annamaria (1)
  • Masiero, Stefano (1)
  • Massara, Maurilio (1)
  • Mazzini, Letizia (1)
  • Muzi, Gianmarco (1)
  • Nasuelli, Nicola (1)
  • Nodari, Laura Rola (1)
  • Novelli, Antonio (1)
  • Pensi, Massimo Projetti (1)
  • Petruzzelli, Francesco (1)
  • Prandi, Paolo (1)
  • Profico, Daniela Celeste (1)
  • Querin, Giorgia (1)
  • Ricciolini, Claudia (1)
  • Sarnelli, Maia Francesca (1)
  • Servo, Serena (1)
  • Sgaravizzi, Giada (1)
  • Soraru, Gianni (1)
  • Spera, Cristina (1)
  • Stecco, Alessandro (1)
  • Torres, Barbara (1)
  • Trombetta, Domenico (1)
  • Vescovi, Angelo L. (1)

Subject

  • Biology, Neuroscience (1)
  • Health Sciences, Medicine and Surgery (1)

Journal

  • Journal of Translational Medicine (1)

Keyword

  • advanc (1)
  • al (1)
  • amyotroph (1)
  • amyotrophiclateralsclerosi (1)
  • biomedicin (1)
  • brain (1)
  • cell (1)
  • cord (1)
  • deliveri (1)
  • experiment (1)
  • foetal (1)
  • human (1)
  • i (1)
  • inject (1)
  • later (1)
  • life (1)
  • medicin (1)
  • microinject (1)
  • neural (1)
  • neurospher (1)
  • outcom (1)
  • phase (1)
  • precursor (1)
  • research (1)
  • safeti (1)
  • scienc (1)
  • sclerosi (1)
  • stem (1)
  • technolog (1)
  • therapeut (1)
  • therapi (1)
  • trial (1)
  • valid (1)

Author department

  • Neurology: Neuromuscular (1)
  • Neurosurgery: Admin (1)

Search Results for all work with filters:

  • Bersano, Enrica
  • Visioli, Alberto
  • Zalfa, Cristina
  • platform

Work 1 of 1

Sorted by relevance

Article

Human neural stem cell transplantation in ALS: initial results from a phase I trial

by Letizia Mazzini; Maurizio Gelati; Daniela Celeste Profico; Giada Sgaravizzi; Massimo Projetti Pensi; Gianmarco Muzi; Claudia Ricciolini; Laura Rola Nodari; Sandro Carletti; Cesare Giorgi; Cristina Spera; Frondizi Domenico; Enrica Bersano; Francesco Petruzzelli; Carlo Cisari; Annamaria Maglione; Maia Francesca Sarnelli; Alessandro Stecco; Giorgia Querin; Stefano Masiero; Roberto Cantello; Daniela Ferrari; Cristina Zalfa; Elena Binda; Alberto Visioli; Domenico Trombetta; Antonio Novelli; Barbara Torres; Laura Bernardini; Alessandro Carriero; Paolo Prandi; Serena Servo; Annalisa Cerino; Valentina Cima; Alessandra Gaiani; Nicola Nasuelli; Maurilio Massara; Jonathan Glass; Gianni Soraru; Angelo L. Vescovi; Nicholas Boulis

2015

Subjects
  • Biology, Neuroscience
  • Health Sciences, Medicine and Surgery
  • File Download
  • View Abstract

Abstract:Close

Background: We report the initial results from a phase I clinical trial for ALS. We transplanted GMP-grade, fetal human neural stem cells from natural in utero death (hNSCs) into the anterior horns of the spinal cord to test for the safety of both cells and neurosurgical procedures in these patients. The trial was approved by the Istituto Superiore di Sanità and the competent Ethics Committees and was monitored by an external Safety Board. Methods: Six non-ambulatory patients were treated. Three of them received 3 unilateral hNSCs microinjections into the lumbar cord tract, while the remaining ones received bilateral (n = 3 + 3) microinjections. None manifested severe adverse events related to the treatment, even though nearly 5 times more cells were injected in the patients receiving bilateral implants and a much milder immune-suppression regimen was used as compared to previous trials. Results: No increase of disease progression due to the treatment was observed for up to18 months after surgery. Rather, two patients showed a transitory improvement of the subscore ambulation on the ALS-FRS-R scale (from 1 to 2). A third patient showed improvement of the MRC score for tibialis anterior, which persisted for as long as 7 months. The latter and two additional patients refused PEG and invasive ventilation and died 8 months after surgery due to the progression of respiratory failure. The autopsies confirmed that this was related to the evolution of the disease. Conclusions: We describe a safe cell therapy approach that will allow for the treatment of larger pools of patients for later-phase ALS clinical trials, while warranting good reproducibility. These can now be carried out under more standardized conditions, based on a more homogenous repertoire of clinical grade hNSCs. The use of brain tissue from natural miscarriages eliminates the ethical concerns that may arise from the use of fetal material.
Site Statistics
  • 16,941
  • Total Works
  • 3,664,996
  • Downloads
  • 1,140,907
  • Downloads This Year
  • 6,807
  • Faculty Profiles

Copyright © 2016 Emory University - All Rights Reserved
540 Asbury Circle, Atlanta, GA 30322-2870
(404) 727-6861
Privacy Policy | Terms & Conditions

v2.2.8-dev

Contact Us Recent and Popular Items
Download now